Skip to content
  • Happy Health
  • Happy Mindset
  • Animal Wonders
  • About Us
    • Team
  • Subscribe
Menu
  • Happy Health
  • Happy Mindset
  • Animal Wonders
  • About Us
    • Team
  • Subscribe
Happy News

Medical Marijuana Got A Major Federal Upgrade

For the first time in more than 50 years, the federal government has fundamentally changed how it classifies medical marijuana, and for millions of patients and researchers, this is a very big deal. Effective April 28, 2026, the Justice Department and the Drug Enforcement Administration officially moved FDA-approved cannabis products and state-licensed medical marijuana from Schedule I to Schedule III of the Controlled Substances Act. Schedule I — the most restrictive category, reserved for substances with “no accepted medical use” — is where marijuana has sat since 1970, alongside heroin. Moving to Schedule III, the same category as ketamine and certain anabolic steroids, is a landmark shift that recognizes what 40 U.S. states have already acknowledged for years: medical marijuana has genuine therapeutic value. For patients, the change could improve access and affordability, as medical cannabis businesses will no longer face a punishing tax rule that had effectively prohibited them from deducting standard business expenses, often pushing effective federal tax rates on those businesses as high as 70 to 80 percent.

For scientists, the rescheduling is equally significant. Schedule I status has long created enormous barriers to cannabis research, making it exceptionally difficult to study a substance tens of millions of Americans already use. Researchers studying everything from chronic pain to epilepsy to PTSD have faced federal restrictions that simply don’t apply to other substances under study. Those barriers will now ease meaningfully. A DEA administrative hearing beginning June 29, 2026, will consider whether the rescheduling extends to all marijuana — including recreational products. For now, the immediate and historic win belongs to the patients, doctors, and researchers who have long argued that science, not stigma, should drive federal drug policy.

Source: https://apnews.com/article/medical-marijuana-rescheduling-justice-department-trump-cannabis-1d6722d3aae122b1a91f8e4b6c690268

PrevPreviousA Pill That Costs Pennies And Has Been Around For 125 Years May Also Fight Cancer

Recent Articles

Happy News

America Just Got Its First-Ever National Strike Fund And Workers Are Fired Up About It

April 25, 2026

For the first time in American history, workers across the country will have a centralized national fund to support them when they organize and strike. Union Now, a new nonprofit launched by Association of Flight Attendants-CWA President Sara Nelson, held its official kickoff rally in Manhattan on April 12 to

Read More
Happy News

Jeopardy Contestant Is On A Historic Winning Streak

April 25, 2026

A 33-year-old law student and former bureaucrat from New Jersey named Jamie Ding has become one of the most exciting things happening on American television right now, racking up 28 consecutive wins on Jeopardy and earning over $730,000 in the process while steadily climbing toward one of the most storied

Read More
Happy News

A Soccer Club For Bereaved Dads Started With Two People And Has Just Won A National Award

April 25, 2026

When two bereaved fathers first showed up to kick a soccer ball around in Blackburn, England, the idea was simple: give men who had lost a child a place to come together through sport, something uncomplicated and human, where grief did not have to be explained or performed. That modest

Read More
« Previous Next »
  • Privacy Notice
  • Accessibility Notice
  • Do Not Sell or Share My Personal Information
  • Unsubscribe
  • Terms and Conditions
  • Privacy Policy
  • Privacy Notice
  • Accessibility Notice
  • Do Not Sell or Share My Personal Information
  • Unsubscribe
  • Terms and Conditions
  • Privacy Policy
Copyright © 2026 HappyNews.